Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients | HTML
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art | Bentham Science
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
CD20 - Wikipedia
Espressione di CD20 sui linfociti B nel midollo osseo ed in periferia.... | Download Scientific Diagram
CD20 as a gatekeeper of the resting state of human B cells | PNAS
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus - ScienceDirect
CD-20 | ドライブレコーダー | セルスター工業株式会社
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives - Kidney International
CD20 CD3 Cancer Immunity Targets | Genentech Oncology
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab | Nature Communications
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better? | SpringerLink
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
